Knight Capital Group’s Zimmer Biomet ZBH Stock Holding History

Knight Capital Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$247K	Buy	+3,399	New	+$254K	﹤0.01%	2480

Other funds holding ZBH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Knight Capital Group's ZBH Position: Q2 2013 in Review

Knight Capital Group opened a new position in Zimmer Biomet (ZBH) in Q2 2013: 13,435 shares worth $978K. The stake represents 0.02% of the portfolio and ranks #1028 among its holdings.

638 funds tracked by Wall St. Rank hold ZBH as of Q2 2013.

Knight Capital Group held 13,435 shares of Zimmer Biomet worth $978K as of Q2 2013.
Zimmer Biomet was a new Knight Capital Group position in Q2 2013.
Zimmer Biomet made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #1028 holding.
638 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.